Palantir's 'unlimited access' to patient data — we examine the US tech giant's controversial…
Who would have thought that the secretive American spytech and data analyst firm, Palantir Technologies, could have gotten so embedded in the UK’s government and public sector?
At first under the radar, Palatnir’s £330 million contract with the NHS is the deal that’s recently caused the headlines.
The news that the NHS has granted Palantir "unlimited access" to identifiable patient health data has come at a moment when the backlash against the American analyst giant has never been stronger.
Two petitions urging the UK government to scrap its contracts with Palantir have already attracted over 200,000 signatures, according to The Guardian, and the UK government is reportedly now considering activating a break clause to end the deal with the NHS by early 2027.
Privacy campaigners and NHS staff alike have expressed deep concerns over how this data-sharing agreement could compromise patient confidentiality.
But is the Palantir-NHS partnership...
Copyright of this story solely belongs to techradar.com. To see the full text click HERE
